1. Home
  2. HCM

HCM

HUTCHMED (China) Limited

Logo HUTCHMED (China) Limited

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 2:30pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

Founded: N/A Country:
N/A
Employees: N/A City: N/A
Market Cap: 2.8B IPO Year: N/A
Target Price: $29.70 AVG Volume (30 days): 133.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.60 EPS Growth: N/A
52 Week Low/High: $10.68 - $20.73 Next Earning Date: 01-01-0001
Revenue: $837,999,000 Revenue Growth: 135.31%
Revenue Growth (this year): -13.66% Revenue Growth (next year): 19.84%

Share on Social Networks: